Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
08/1999
08/11/1999EP0934285A1 Substituting 2-amino-4-alkylamino-1,3,5-triazine as herbicide
08/11/1999EP0933993A1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
08/10/1999US5935601 Acylated peptide as a carrier for oral administration
08/04/1999EP0933367A1 Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
08/04/1999EP0932604A1 Substituted 2,4-diamino-1,3,5-triazines as herbicides
08/04/1999EP0575490B1 GnRH ANALOGS
08/04/1999CN1224718A Thiazole derivatives
08/03/1999US5932583 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides
08/03/1999US5932267 Carboxy derivatives of aminoimidazolines, imparting a thick, sour taste to foods
07/1999
07/29/1999WO1999037294A2 Mitochondria protecting agents for treating mitochondria associated diseases
07/29/1999CA2319131A1 Mitochondria protecting agents for treating mitochondria associated diseases
07/28/1999CN1224416A Creatine pyruvates and method for their production
07/27/1999US5929120 Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption
07/27/1999US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
07/21/1999EP0929302A1 Il-8 receptor antagonists
07/21/1999CN1044249C Matrix metalloprotease inhibitors
07/13/1999US5922772 Therapeutic substituted guanidines
07/13/1999US5922763 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
07/08/1999WO1999033781A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
07/08/1999WO1999033460A1 Acyl guanidine sodium/proton exchange inhibitors and method
07/08/1999CA2316352A1 Acyl guanidine sodium/proton exchange inhibitors and method
07/06/1999US5919765 Inhibitors of factor XA
07/01/1999WO1999032457A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
07/01/1999WO1999032433A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
07/01/1999WO1999032158A2 Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
07/01/1999CA2312712A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
07/01/1999CA2300197A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
06/1999
06/30/1999EP0925063A1 Hypoglycemic and hypolipidemic compounds
06/24/1999WO1999031052A1 Novel metalloproteinase inhibitors
06/24/1999WO1999031049A1 Neuroprotective agents
06/24/1999CA2313649A1 Novel metalloproteinase inhibitors
06/23/1999EP0923600A2 Novel cationic amphiphilic lipids for liposomal gene transfer
06/17/1999WO1999029677A1 Substituted 2,4-diamino-1,3,5-triazines
06/17/1999WO1999029314A1 Novel salts of metformin and method
06/17/1999DE19755016A1 Substituierte 2,4-Diamino-1,3,5-triazine Substituted 2,4-diamino-1,3,5-triazines
06/17/1999CA2314334A1 Substituted 2,4-diamino-1,3,5-triazines
06/16/1999EP0684830B1 Inhibitors of thrombosis
06/09/1999EP0921117A2 Acylguanidines
06/09/1999EP0920434A2 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/08/1999CA2089972C Sulfonamidocarboxamides
06/02/1999EP0918460A1 Methods of treatment of eye trauma and disorders
06/02/1999EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
06/02/1999CN1218039A The preparation of substituted guanidine derivatives
06/02/1999CN1218038A The preparation of substituted guanidine derivatives
06/02/1999CN1218037A The preparation of substituted guanidine derivatives
06/02/1999CN1218036A The preparation of substituted guanidine derivatives
05/1999
05/12/1999EP0915085A2 Process for the preparation of substituted guanidine derivatives
05/12/1999EP0915084A2 Process for the preparation of substituted guanidine derivatives
05/12/1999EP0915083A2 Process for the preparation of substituted guanidine derivatives
05/12/1999EP0915082A2 Process for the preparation of substituted guanidine derivatives
05/06/1999WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
05/04/1999US5900436 Therapy for lipid metabolism disorders
04/1999
04/29/1999WO1999020599A1 Pharmaceutically active compounds and methods of use
04/29/1999CA2307597A1 Pharmaceutically active compounds and methods of use
04/28/1999EP0911026A1 Creatine derivatives for asthma
04/22/1999WO1998052917A3 Guanidinylation reagents
04/21/1999CN1214691A Process for preparation of N-methyl-D-phenylalanyl-N-[1-[3-[(aminoiminomethyl)-amino] propyl]-3,3-difluoro-2-oxohexyl]-L-prolinamide
04/15/1999WO1999018053A1 Preparation of radiolabelled haloaromatics via polymer-bound intermediates
04/14/1999EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS
04/14/1999EP0767777B1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations
04/13/1999CA2143216C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
04/13/1999CA2110437C 15-deoxysperqualin analogs, their method of preparation and their use in therapeutics
04/08/1999WO1999016427A1 Active agent transport systems
04/08/1999CA2304951A1 Active agent transport systems
04/06/1999CA2024700C Benzoylguanidines, a process for their preaparation, their use as medicaments and medicaments containing them
04/01/1999WO1999015498A1 New npy antagonists
04/01/1999WO1999015493A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
04/01/1999WO1999015490A1 C3a receptor ligands
04/01/1999CA2304879A1 New tetracycles, process for their production and pharmaceutical preparations containing these compounds
04/01/1999CA2303883A1 C3a receptor ligands
04/01/1999CA2303528A1 New npy antagonists
03/1999
03/31/1999EP0701550B1 Process for the production of aminoalkylguanidines
03/25/1999WO1999014185A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/25/1999DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors
03/25/1999CA2303323A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/24/1999EP0673432B1 Process for preparing clavulanic acid
03/24/1999EP0664786B1 Arginine keto-amide enzyme inhibitors
03/23/1999US5886146 Inhibitors of thrombosis
03/23/1999US5885990 Fibrinolysis promoting action; thrombolysis action
03/16/1999US5883133 Cardiovascular disorders
03/16/1999US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis
03/16/1999US5883130 Ng-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock
03/16/1999US5882833 Colors and aromatic sulfonic acid salts
03/09/1999US5880156 Antiarrhythmia agents
03/02/1999US5876747 Liposome preferentially traveling to cardiac and skeletal muscles
02/1999
02/25/1999WO1999008673A1 Enantiomers of 4-[[(cyanoimino)- [(1,2,2-trimethylpropyl) amino]methyl]amino] benzonitrile
02/25/1999WO1998005678A3 Novel cationic amphiphilic lipids for liposomal gene transfer
02/25/1999CA2300414A1 Enantiomers of 4-¬¬(cyanoimino)- ¬(1,2,2-trimethylpropyl) amino|methyl|amino| benzonitrile
02/24/1999EP0703900B1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES
02/23/1999US5874472 Aminoacid derivatives as no synthase inhibitors
02/23/1999US5874436 Effective in inhibiting the action of a bacterial histidine protein kinase; useful against antibiotic resistant organisms
02/16/1999US5872294 Phase transfer agents of hexasubstituted guanidium chlorides
02/09/1999US5869734 Chemical intermediate to the production of deoxyspergualin and salts
02/09/1999US5869531 No undesireable salidiuretic properties; treating ischemia induced disorders
02/09/1999US5869454 Arginine keto-amide enzyme inhibitors
02/09/1999US5869299 Using an enzyme system from streptomyces, particularly s. clavuligerus.
02/09/1999CA1340385C Recovery of precious metals
02/04/1999WO1999005094A1 Novel compositions for the delivery of negatively charged molecules
02/04/1999CA2300695A1 Novel compositions for the delivery of negatively charged molecules
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 54